Augmenting Pre-Operative Risk of Recurrence Stratification in DTC
R. Michael Tuttle, MD, discusses a study that looked at augmenting pre-operative risk of recurrence stratification in differentiated thyroid carcinoma.
Clinical Pearls
R. Michael Tuttle, MD, professor of medicine, Memorial Sloan Kettering Cancer Center, discusses a study that looked at augmenting pre-operative risk of recurrence stratification in differentiated thyroid carcinoma.
- This study set out to determine if data obtained during pre-operative nodule biopsy could be used to augment risk stratification.
- The ensemble classifier correctly identified 72.4% (21/29) of low risk tumors and 82.6% (43/52) of intermediate/high risk tumors.
- This represents another piece of information to help a physician decide on the proper approach to surgery.
Recent Videos
Related Content
Anticipating Novel Options for the RAI-Refractory DTC Armamentarium
May 15th 2023Podcast
In season 4, episode 6 of Targeted Talks, Warren Swegal, MD, takes a multidisciplinary look at the RAI-refractory differentiated thyroid cancer treatment landscape, including the research behind 2 promising systemic therapy options.
Listen
